Unknown

Dataset Information

0

Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.


ABSTRACT: Hepatitis B virus (HBV) has extremely restricted host and hepatocyte tropism. HBV-based vectors could form the basis of novel therapies for chronic hepatitis B and other liver diseases and would also be invaluable for the study of HBV infection. Previous attempts at developing HBV-based vectors encountered low yields of recombinant viruses and/or lack of sufficient infectivity/cargo gene expression in primary hepatocytes, which hampered follow-up applications. In this work, we constructed a novel vector based on a naturally occurring, highly replicative HBV mutant with a 207-bp deletion in the preS1/polymerase spacer region. By applying a novel insertion strategy that preserves the continuity of the polymerase open reading frame (ORF), recombinant HBV (rHBV) carrying protein or small interfering RNA (siRNA) genes were obtained that replicated and were packaged efficiently in cultured hepatocytes. We demonstrated that rHBV expressing a fluorescent reporter (DsRed) is highly infective in primary tree shrew hepatocytes, and rHBV expressing HBV-targeting siRNA successfully inhibited antigen expression from coinfected wild-type HBV. This novel HBV vector will be a powerful tool for hepatocyte-targeting gene delivery, as well as the study of HBV infection.

SUBMITTER: Hong R 

PROVIDER: S-EPMC3676104 | biostudies-literature | 2013 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.

Hong Ran R   Bai Weiya W   Zhai Jianwei J   Liu Wei W   Li Xinyan X   Zhang Jiming J   Cui Xiaoxian X   Zhao Xue X   Ye Xiaoli X   Deng Qiang Q   Tiollais Pierre P   Wen Yumei Y   Liu Jing J   Xie Youhua Y  

Journal of virology 20130403 12


Hepatitis B virus (HBV) has extremely restricted host and hepatocyte tropism. HBV-based vectors could form the basis of novel therapies for chronic hepatitis B and other liver diseases and would also be invaluable for the study of HBV infection. Previous attempts at developing HBV-based vectors encountered low yields of recombinant viruses and/or lack of sufficient infectivity/cargo gene expression in primary hepatocytes, which hampered follow-up applications. In this work, we constructed a nove  ...[more]

Similar Datasets

| S-EPMC4885084 | biostudies-literature
| S-EPMC104078 | biostudies-literature
| S-EPMC6034586 | biostudies-literature
| S-EPMC3640030 | biostudies-literature
| S-EPMC2634964 | biostudies-literature
| S-EPMC8347318 | biostudies-literature
2024-05-02 | PXD051216 | Pride
| S-EPMC8073075 | biostudies-literature
| S-EPMC9834420 | biostudies-literature
| S-EPMC4792598 | biostudies-literature